Acute Pulmonary Infections

  • Karen S. Powers


Acute lower respiratory infection is a common cause of morbidity in infants and children, and at times, requires intensive care and mechanical ventilation. Viral bronchiolitis and bacterial pneumonia account for the majority of lower respiratory tract infections that lead to respiratory insufficiency and pediatric intensive care admission. Twenty-seven percent of children who require mechanical ventilation for at least 24 h in pediatric intensive care units are diagnosed with bronchiolitis and 16% have the diagnosis of pneumonia. The median length of time intubated for an acute pulmonary infection leading to respiratory failure is approximately 7 days.


Mechanical Ventilation Respiratory Syncytial Virus Pediatric Intensive Care Unit Methicillin Resistant Staphylococcus Aureus Bronchopulmonary Dysplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Readings

  1. Allander T, Jartti T, Gupta S, et al. Human bocavirus and acute wheezing in children. Clin Infect Dis. 2007;44:904–10.PubMedCrossRefGoogle Scholar
  2. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and Management of Bronchiolitis. Pediatrics. 2006;118:1774–93.CrossRefGoogle Scholar
  3. Bar-Zohar D, Sivan Y. The yield of flexible fiberoptic bronchoscopy in pediatric intensive care patients. Chest. 2004;126:1353–9.PubMedCrossRefGoogle Scholar
  4. Bont L, Kimpen JL. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Intensive Care Med. 2002;28: 616–21.PubMedCrossRefGoogle Scholar
  5. Caracciolo S, Minini C, Colombrita D, et al. Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features. Pediatr Infect Dis. 2008;27:406–12.CrossRefGoogle Scholar
  6. Corneli HM, Zorc JJ, Majahan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med. 2007;357:331–9.PubMedCrossRefGoogle Scholar
  7. DeVincenzo JP. Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load. Pediatr Res. 2004;56:914–7.PubMedCrossRefGoogle Scholar
  8. Dobson JV, Stephens-Groff SM, McMahon SR, et al. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics. 1998;101:361–8.PubMedCrossRefGoogle Scholar
  9. Domachowske JB, Rosenberg HF. Advances in the treatment and prevention of severe viral bronchiolitis. Pediatr Ann. 2005;34:35–41.PubMedGoogle Scholar
  10. Feldman C, Kessel M, Cantrell J, et al. The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J. 1999;13:546–51.PubMedCrossRefGoogle Scholar
  11. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003;143:532–40.PubMedCrossRefGoogle Scholar
  12. Garrison MM, Christakis D, Harvey E, Cummings PP, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics. 2000;105:e44.PubMedCrossRefGoogle Scholar
  13. Gates RL, Hogan M, Weinstein S, Arca MJ. Drainage, fibrinolytics, or surgery: a comparison of treatment options in pediatric empyema. J Pediatr Surg. 2004;39:1638–42.PubMedCrossRefGoogle Scholar
  14. Gates RL, Caniano D, Hayes JR, Arca MJ. Does VATS provide optimal treatment of empyema in children? A systematic review. J Pediatr Surg. 2004;39:381–6.PubMedCrossRefGoogle Scholar
  15. Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics. 2002;110:e9.PubMedCrossRefGoogle Scholar
  16. Leung CW, Chiu WK. Clinical picture, diagnosis, treatment, and outcome of severe acute respiratory syndrome (SARS) in children. Paediatr Respir Rev. 2004;5:275–88.PubMedCrossRefGoogle Scholar
  17. Liet JM, Millotte B, Tucci M, Laflammme S, Hutchison J, Creery D. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr. 2005;147:812–7.PubMedCrossRefGoogle Scholar
  18. Light RW. Pleural effusion. N Engl J Med. 2002;346:1971–7.PubMedCrossRefGoogle Scholar
  19. Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507–13.PubMedGoogle Scholar
  20. Mandelberg A, Tal G, Witzling M, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest. 2003;123:481–7.PubMedCrossRefGoogle Scholar
  21. Martinez F. Development of wheezing disorders and asthma in preschool children. Pediatrics. 2002;109(2 Suppl):362–7.PubMedGoogle Scholar
  22. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics. 2002;109:68–73.PubMedCrossRefGoogle Scholar
  23. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Nasal continuous positive airway pressure with heliox versus air oxygen in infants with acute bronchiolitis: a crossover study. Pediatrics. 2008;121:e1190–5.PubMedCrossRefGoogle Scholar
  24. McCracken GH. Diagnosis and management of pneumonia in children. Pediatr Infect Dis J. 2000;19:924–8.PubMedCrossRefGoogle Scholar
  25. McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429–37.PubMedCrossRefGoogle Scholar
  26. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J. 2003;22:S40–5.PubMedCrossRefGoogle Scholar
  27. Milder E, Arnold JC. Human metapneumovirus and human bocavirus in children. Pediatr Res. 2009;65:78R–83R.PubMedCrossRefGoogle Scholar
  28. Paranhos-Baccalá G, Komurian-Pradel F, Richard N, Vernet G, Lina B, Floret D. Mixed respiratory virus infections. J Clin Virol. 2008;43:407–10.PubMedCrossRefGoogle Scholar
  29. Principi N, Esposito S. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients. Curr Opin Infect Dis. 2002;15:295–300.PubMedCrossRefGoogle Scholar
  30. Purcell K, Fergie J. Driscoll Children’s Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991–2002. Pediatr Infect Dis J. 2004;23:418–23.PubMedCrossRefGoogle Scholar
  31. Ramos MM, Overturf GD, Crowley MR, Rosenberg RB, Hjelle B. Infection with sin nombre hantavirus: clinical presentation and outcome in children and adolescents. Pediatrics. 2001;108:e27.PubMedCrossRefGoogle Scholar
  32. Randolph AG, Wang EE. Ribavirin for respiratory syncytial virus lower respiratory tract infection: a systematic overview. Arch Pediatr Adolesc Med. 1996;150:942–7.PubMedCrossRefGoogle Scholar
  33. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J. 2004;23:990–4.PubMedCrossRefGoogle Scholar
  34. Richard N, Hackme C, Stamm D, Floret D. Influenza in pediatric intensive cure unit. Arch Pediatr. 2004;11:879–84.PubMedCrossRefGoogle Scholar
  35. Schindler M. Do bronchodilators have an effect on bronchiolitis? Crit Care. 2002;6:111–2.PubMedCrossRefGoogle Scholar
  36. Shetty AK, Treynor E, Hill DW, Gutierrez KM, Warford A, Baron EJ. Comparison of conventional viral cultures with direct fluorescent antibody stains for diagnosis of community-acquired respiratory virus infections in hospitalized children. Pediatr Infect Dis J. 2003;22:789–94.PubMedCrossRefGoogle Scholar
  37. Simoes EA, Sondheimer H, Top FH, et al. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. J Pediatr. 1998;133:492–9.PubMedCrossRefGoogle Scholar
  38. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541–5.PubMedCrossRefGoogle Scholar
  39. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc. 2010;85:64–76.PubMedCrossRefGoogle Scholar
  40. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–7.CrossRefGoogle Scholar
  41. Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax. 2006;61:611–5.PubMedCrossRefGoogle Scholar
  42. Vitali SH, Arnold JH. Bench-to-bedside review: ventilator strategies to reduce lung injury – lessons from pediatric and neonatal intensive care. Crit Care. 2005;9:177–83.PubMedCrossRefGoogle Scholar
  43. Vuori-Holopainen E, Salo E, Saxén H, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. CID. 2002;34:583–90.CrossRefGoogle Scholar
  44. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med. 2003;349:27–35.PubMedCrossRefGoogle Scholar
  45. Welliver RC. Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J. 2003;22:S6–12.PubMedCrossRefGoogle Scholar
  46. Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA. 2005;293:470–6.PubMedCrossRefGoogle Scholar
  47. Wilmott RW, Khurana-Hershey G, Stark JM. Current concepts on pulmonary host defense mechanisms in children. Curr Opin Pediatr. 2000;12:187–93.PubMedCrossRefGoogle Scholar
  48. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2008;4:CD006458.PubMedGoogle Scholar
  49. Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010;125:342–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  • Karen S. Powers
    • 1
  1. 1.Pediatric Critical Care Medicine, Department of PediatricsUniversity of Rochester School of Medicine and Dentistry, Golisano Children’s HospitalRochesterUSA

Personalised recommendations